Humana (NYSE:HUM) Reaches New 1-Year High – Should You Buy?

Shares of Humana Inc. (NYSE:HUM) hit a new 52-week high during mid-day trading on Thursday . The company traded as high as $369.34 and last traded at $365.8880, with a volume of 959547 shares traded. The stock had previously closed at $363.18.

Analyst Ratings Changes

HUM has been the subject of a number of research analyst reports. Wolfe Research upgraded Humana from a “hold” rating to a “strong-buy” rating in a research note on Thursday, June 4th. Oppenheimer upgraded Humana from an “outperform” rating to an “outperform” rating in a research note on Wednesday, May 20th. Guggenheim lifted their price target on Humana from $252.00 to $269.00 and gave the company a “buy” rating in a research report on Thursday, April 30th. Wells Fargo & Company lowered Humana from a “cautious” rating to a “reduce” rating in a research report on Wednesday, May 20th. Finally, The Goldman Sachs Group raised their price objective on shares of Humana from $158.00 to $195.00 and gave the stock a “sell” rating in a research note on Thursday, April 30th. One investment analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, fourteen have assigned a Hold rating and four have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $286.13.

Humana Trading Up 0.7%

The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.66. The company has a market capitalization of $43.93 billion, a price-to-earnings ratio of 39.13, a PEG ratio of 2.08 and a beta of 0.76. The company has a fifty day moving average of $259.94 and a 200-day moving average of $235.20.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.97 by $0.34. Humana had a return on equity of 10.45% and a net margin of 0.82%.The company had revenue of $39.65 billion for the quarter, compared to analysts’ expectations of $39.37 billion. During the same period in the previous year, the firm posted $11.58 EPS. Humana’s revenue was up 23.5% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.000- EPS. As a group, equities research analysts anticipate that Humana Inc. will post 9 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.0%. The ex-dividend date is Friday, June 26th. Humana’s payout ratio is presently 37.86%.

Institutional Investors Weigh In On Humana

Institutional investors have recently bought and sold shares of the company. Montag A & Associates Inc. boosted its holdings in Humana by 1,880.0% in the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after buying an additional 94 shares during the last quarter. CoreCap Advisors LLC boosted its holdings in Humana by 54.4% in the 4th quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock worth $27,000 after buying an additional 37 shares during the last quarter. Fideuram Asset Management Ireland dac acquired a new stake in Humana in the 4th quarter worth about $27,000. Reflection Asset Management acquired a new stake in Humana in the 4th quarter worth about $29,000. Finally, Rosenberg Matthew Hamilton boosted its holdings in shares of Humana by 136.0% during the 4th quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock worth $30,000 after purchasing an additional 68 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.